Process for the preparation of kinase inhibitors and intermediates thereof

US10550087B2 · kind B2 · utility

Assignee

• Aerie Pharmaceuticals, Inc. · US

Inventors

• Jill Marie Sturdivant · Chapel Hill, US
• Mitchell A. deLong · Chapel Hill, US
• Gilles Chambournier · Ann Arbor, US
• Michael Pamment · Holland, US
• Victor Fedij · Brighton, US

Key dates

• Filing date: Nov 17, 2015
• Grant date: Feb 4, 2020
• Expiry date: Nov 17, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Described are processes for the synthesis of certain compounds, useful for treating diseases, e.g. eye disease, such as glaucoma and ocular hypertension, in a subject.